Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca S Bahn

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|August 30, 2008
Is radioiodine more likely than antithyroid drugs to worsen ophthalmopathy in patients with Graves disease?Rebecca S Bahn
Journal of Translational Internal Medicine|February 14, 2017
Graves' disease syndrome: a need for unified therapyRebecca S Bahn
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of diseaseRebecca S Bahn
Nature Clinical Practice. Endocrinology & Metabolism|August 29, 2007
Is orbital decompression a safe and effective treatment for Graves' orbitopathy?Rebecca S Bahn
The New England Journal of Medicine|February 26, 2010
Graves' ophthalmopathyRebecca S Bahn
Thyroid : Official Journal of the American Thyroid Association|April 16, 2002
Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathyRebecca S Bahn
Expert Review of Clinical Pharmacology|December 14, 2012
Emerging pharmacotherapy for treatment of Graves' diseaseRebecca S Bahn
Endocrinology|August 27, 2013
News and views: at long last, an animal model of Graves' orbitopathyRebecca S Bahn
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathySeema Kumar, Rebecca S Bahn
Mayo Clinic Proceedings|September 9, 2008
How perceived physician leadership behavior affects physician satisfactionRonald Menaker, Rebecca S Bahn
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Nature Clinical Practice. Endocrinology & Metabolism|August 30, 2008
Is radioiodine more likely than antithyroid drugs to worsen ophthalmopathy in patients with Graves disease?Rebecca S Bahn
Journal of Translational Internal Medicine|February 14, 2017
Graves' disease syndrome: a need for unified therapyRebecca S Bahn
The Journal of Clinical Endocrinology and Metabolism|May 3, 2003
Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of diseaseRebecca S Bahn
Nature Clinical Practice. Endocrinology & Metabolism|August 29, 2007
Is orbital decompression a safe and effective treatment for Graves' orbitopathy?Rebecca S Bahn
The New England Journal of Medicine|February 26, 2010
Graves' ophthalmopathyRebecca S Bahn
Thyroid : Official Journal of the American Thyroid Association|April 16, 2002
Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathyRebecca S Bahn
Expert Review of Clinical Pharmacology|December 14, 2012
Emerging pharmacotherapy for treatment of Graves' diseaseRebecca S Bahn
Endocrinology|August 27, 2013
News and views: at long last, an animal model of Graves' orbitopathyRebecca S Bahn
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathySeema Kumar, Rebecca S Bahn
Mayo Clinic Proceedings|September 9, 2008
How perceived physician leadership behavior affects physician satisfactionRonald Menaker, Rebecca S Bahn
Pageof 6